Viridian Therapeutics, Inc. has grown revenue 264% a year over three years and 94% a year over five. Revenue growth, 3-year annual rate: +264% (Biotechnology median +21%). Revenue growth, 5-year rate: +94%, growth has picked up over the last three years. Years of annual history on file: 13, FY2013 to FY2025, as filed.

VRDNViridian Therapeutics, Inc.

HealthcareUSD

$24.25

$13.3052 weeks$33.78

Is it growing?

Is VRDN growing?

Viridian Therapeutics, Inc. has grown revenue 264% a year over three years and 94% a year over five.

+264%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +94%
Revenue growth, 5-year rate · +264% over three · growth has picked up over the last three years
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed

Details›